应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02179 瑞科生物-B
未开盘 02-19 16:08:20
9.150
+0.110
+1.22%
最高
9.300
最低
9.000
成交量
24.15万
今开
9.100
昨收
9.040
日振幅
3.32%
总市值
44.19亿
流通市值
28.93亿
总股本
4.83亿
成交额
221.26万
换手率
0.08%
流通股本
3.16亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
瑞科生物-B盘中异动 早盘大幅下跌9.88%报8.210港元
市场透视 · 02-17 01:32
瑞科生物-B盘中异动 早盘大幅下跌9.88%报8.210港元
瑞科生物-B盘中异动 急速下挫10.79%报8.100港元
市场透视 · 02-14
瑞科生物-B盘中异动 急速下挫10.79%报8.100港元
瑞科生物九价HPV疫苗获新进展,股价竟萎靡不振?
财华社 · 02-13
瑞科生物九价HPV疫苗获新进展,股价竟萎靡不振?
瑞科生物(02179.HK)重组九价HPV疫苗临床试验申请获受理
阿斯达克财经 · 02-12
瑞科生物(02179.HK)重组九价HPV疫苗临床试验申请获受理
【瑞科生物-B(02179.HK)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理】瑞科生物-B(02179.HK)发布公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c (REC604c)临床试验申请。
金融界 · 02-12
【瑞科生物-B(02179.HK)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理】瑞科生物-B(02179.HK)发布公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c (REC604c)临床试验申请。
瑞科生物-B(02179)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理
智通财经 · 02-12
瑞科生物-B(02179)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理
瑞科生物-B盘中异动 股价大涨5.30%报9.140港元
市场透视 · 02-12
瑞科生物-B盘中异动 股价大涨5.30%报9.140港元
瑞科生物-B(02179)股价上升5.3%,现价港币$9.14
阿斯达克财经 · 02-12
瑞科生物-B(02179)股价上升5.3%,现价港币$9.14
瑞科生物-B盘中异动 早盘急速上涨5.08%报8.680港元
市场透视 · 02-11
瑞科生物-B盘中异动 早盘急速上涨5.08%报8.680港元
瑞科生物-B(02179)股价上升5.085%,现价港币$8.68
阿斯达克财经 · 02-11
瑞科生物-B(02179)股价上升5.085%,现价港币$8.68
瑞科生物-B盘中异动 临近收盘股价大跌6.02%
市场透视 · 01-09
瑞科生物-B盘中异动 临近收盘股价大跌6.02%
盘中股价逆市上涨近10%,瑞科生物-B(02179)能否在商业化关键年摆脱流动性陷阱
智通财经 · 01-08
盘中股价逆市上涨近10%,瑞科生物-B(02179)能否在商业化关键年摆脱流动性陷阱
瑞科生物-B盘中异动 急速上涨9.01%
市场透视 · 01-08
瑞科生物-B盘中异动 急速上涨9.01%
瑞科生物新疫苗III期临床研究已完成全部受试者入组
财中社 · 01-02
瑞科生物新疫苗III期临床研究已完成全部受试者入组
瑞科生物:新佐剂重组带状疱疹疫苗REC610完成III期临床研究入组
金吾资讯 · 01-02
瑞科生物:新佐剂重组带状疱疹疫苗REC610完成III期临床研究入组
【瑞科生物-B(02179.HK)新佐剂重组带状疱疹疫苗REC610 完成III期临床研究入组】瑞科生物-B(02179.HK)公布,公司自主研发的新佐剂重组带状疱疹疫苗 REC610 III期临床研究已顺利完成全部受试者的入组。
金融界 · 01-02
【瑞科生物-B(02179.HK)新佐剂重组带状疱疹疫苗REC610 完成III期临床研究入组】瑞科生物-B(02179.HK)公布,公司自主研发的新佐剂重组带状疱疹疫苗 REC610 III期临床研究已顺利完成全部受试者的入组。
瑞科生物-B(02179)新佐剂重组带状疱疹疫苗REC610 完成III期临床研究入组
智通财经 · 01-02
瑞科生物-B(02179)新佐剂重组带状疱疹疫苗REC610 完成III期临床研究入组
瑞科生物(02179.HK)预防带状疱疹疫苗临床研究完成全部受试者入组
阿斯达克财经 · 01-02
瑞科生物(02179.HK)预防带状疱疹疫苗临床研究完成全部受试者入组
瑞科生物-B(02179)股价显著上升11.006%,现价港币$9.38
阿斯达克财经 · 2024-12-30
瑞科生物-B(02179)股价显著上升11.006%,现价港币$9.38
瑞科生物-B盘中异动 股价大涨6.51%报9.000港元
市场透视 · 2024-12-30
瑞科生物-B盘中异动 股价大涨6.51%报9.000港元
加载更多
公司概况
公司名称:
瑞科生物-B
所属市场:
SEHK
上市日期:
--
主营业务:
江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。该公司拥有一系列临床和临床前阶段的疫苗,人乳头瘤病毒(HPV)疫苗管线包括重组HPV九价候选疫苗REC603,重组HPV二价候选疫苗REC601及REC602,重组HPV四价疫苗REC604a以及重组HPV九价疫苗REC604b。该公司还参与新冠病毒疫苗的研发。该公司主要在国内市场销售其产品。
发行价格:
--
{"stockData":{"symbol":"02179","market":"HK","secType":"STK","nameCN":"瑞科生物-B","latestPrice":9.15,"timestamp":1739952500013,"preClose":9.04,"halted":0,"volume":241500,"delay":0,"floatShares":316138689,"shares":482963000,"eps":-1.2700176028280536,"marketStatus":"未开盘","change":0.11,"latestTime":"02-19 16:08:20","open":9.1,"high":9.3,"low":9,"amount":2212575,"amplitude":0.033186,"askPrice":9.2,"askSize":1000,"bidPrice":9.04,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-1.2221179800107338,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1740015000000},"marketStatusCode":0,"adr":0,"listingDate":1648656000000,"exchange":"SEHK","adjPreClose":9.04,"openAndCloseTimeList":[[1739928600000,1739937600000],[1739941200000,1739952000000]],"volumeRatio":1.5363514087622527,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02179","defaultTab":"news","newsList":[{"id":"2512964914","title":"瑞科生物-B盘中异动 早盘大幅下跌9.88%报8.210港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512964914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512964914?lang=zh_cn&edition=full","pubTime":"2025-02-17 09:32","pubTimestamp":1739755975,"startTime":"0","endTime":"0","summary":"2025年02月17日早盘09时32分,瑞科生物-B股票出现波动,股价快速跳水9.88%。截至发稿,该股报8.210港元/股,成交量7500股,换手率0.00%,振幅9.77%。资金方面,该股资金流入0港元,流出5.881万港元。瑞科生物-B股票所在的生物技术行业中,整体涨幅为0.70%。其相关个股中,科济药业-B、晶泰控股-P、基石药业-B涨幅较大,振幅较大的相关个股有科笛-B、瑞科生物-B、基石药业-B,振幅分别为9.88%、9.77%、7.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502170932569887fd26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502170932569887fd26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2511471686","title":"瑞科生物-B盘中异动 急速下挫10.79%报8.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511471686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511471686?lang=zh_cn&edition=full","pubTime":"2025-02-14 10:15","pubTimestamp":1739499309,"startTime":"0","endTime":"0","summary":"2025年02月14日早盘10时15分,瑞科生物-B股票出现波动,股价急速下跌10.79%。截至发稿,该股报8.100港元/股,成交量6.8万股,换手率0.02%,振幅13.33%。瑞科生物-B股票所在的生物技术行业中,整体涨幅为2.67%。瑞科生物-B公司简介:江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。消息层面,截至10时15分,《瑞科生物-B新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理》资讯为影响瑞科生物-B的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141015099884ccc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141015099884ccc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2511513713","title":"瑞科生物九价HPV疫苗获新进展,股价竟萎靡不振?","url":"https://stock-news.laohu8.com/highlight/detail?id=2511513713","media":"财华社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511513713?lang=zh_cn&edition=full","pubTime":"2025-02-13 14:32","pubTimestamp":1739428349,"startTime":"0","endTime":"0","summary":"2月12日,港股的瑞科生物(02179.HK)发布公告称,公司近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c的临床试验申请。","market":"other","thumbnail":"https://images.finet.hk/photoLib/title/202502_1/6430a70d-5888-476d-8512-761dc83ea647.png","type":0,"news_type":0,"thumbnails":["https://images.finet.hk/photoLib/title/202502_1/6430a70d-5888-476d-8512-761dc83ea647.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.finet.hk/newscenter/news_content/67ad91fd5a7712d0652496cc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"finet_stock","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2511030417","title":"瑞科生物(02179.HK)重组九价HPV疫苗临床试验申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2511030417","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511030417?lang=zh_cn&edition=full","pubTime":"2025-02-13 00:26","pubTimestamp":1739377560,"startTime":"0","endTime":"0","summary":"瑞科生物-B(02179.HK) 公布,近日收到国家药品监督管理局通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c临床试验申请。REC604c是公司计划针对男性市场和升级市场开发的新型重组九价HPV疫苗。(de/d)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20200103175221798_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20200103175221798_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1416820/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03347","BK1161","BK1141","BK1583","02179","159646","BK1576"],"gpt_icon":0},{"id":"2510376095","title":"【瑞科生物-B(02179.HK)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理】瑞科生物-B(02179.HK)发布公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c (REC604c)临床试验申请。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510376095","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510376095?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:55","pubTimestamp":1739364948,"startTime":"0","endTime":"0","summary":"瑞科生物-B(02179.HK)发布公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c (REC604c)临床试验申请。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/12205548120638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02179","BK1576","BK1583","159646","BK1161","03347","BK1141"],"gpt_icon":0},{"id":"2510376959","title":"瑞科生物-B(02179)新佐剂重组九价HPV疫苗REC604c中国临床试验申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2510376959","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510376959?lang=zh_cn&edition=full","pubTime":"2025-02-12 20:46","pubTimestamp":1739364391,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞科生物-B 发布公告,集团已于近日收到国家药品监督管理局签发的受理通知书,同意受理其自主研发的新佐剂重组九价HPV疫苗REC604c 临床试验申请。REC604c是公司计划针对男性市场和升级市场开发的新型重组九价HPV疫苗。临床前研究表明,在相同免疫剂量下,接种两针REC604c诱导产生的免疫原性总体优于默沙东Gardasil9三针免疫水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249074.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03347","159646","BK1161","02179","BK1576","BK1583","BK1141"],"gpt_icon":0},{"id":"2510319924","title":"瑞科生物-B盘中异动 股价大涨5.30%报9.140港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510319924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510319924?lang=zh_cn&edition=full","pubTime":"2025-02-12 13:04","pubTimestamp":1739336684,"startTime":"0","endTime":"0","summary":"2025年02月12日下午盘13时04分,瑞科生物-B股票出现波动,股价大幅拉升5.30%。截至发稿,该股报9.140港元/股,成交量2.35万股,换手率0.01%,振幅3.92%。资金方面,该股资金流入15.393万港元,流出4.8665万港元。瑞科生物-B股票所在的生物技术行业中,整体涨幅为0.03%。其相关个股中,科笛-B、北海康成-B、药明巨诺-B涨幅较大,振幅较大的相关个股有科笛-B、北海康成-B、药明巨诺-B,振幅分别为22.41%、13.28%、11.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212130444a242c30f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212130444a242c30f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2510319441","title":"瑞科生物-B(02179)股价上升5.3%,现价港币$9.14","url":"https://stock-news.laohu8.com/highlight/detail?id=2510319441","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510319441?lang=zh_cn&edition=full","pubTime":"2025-02-12 13:04","pubTimestamp":1739336640,"startTime":"0","endTime":"0","summary":"[上升股]瑞科生物-B(02179) 股价在下午01:04比前收市价上升5.3%,现股价为港币$9.14。至目前为止,今日最高价为$9.14,而最低价为$8.8。总成交量为2.35万股,总成交金额为港币$21.156万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502124011/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2510408458","title":"瑞科生物-B盘中异动 早盘急速上涨5.08%报8.680港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510408458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510408458?lang=zh_cn&edition=full","pubTime":"2025-02-11 10:55","pubTimestamp":1739242512,"startTime":"0","endTime":"0","summary":"2025年02月11日早盘10时55分,瑞科生物-B股票出现异动,股价大幅上涨5.08%。截至发稿,该股报8.680港元/股,成交量3.1万股,换手率0.01%,振幅7.14%。瑞科生物-B股票所在的生物技术行业中,整体跌幅为1.35%。其相关个股中,基石药业-B、华康生物医学、中国抗体-B涨幅较大,振幅较大的相关个股有基石药业-B、加科思-B、云顶新耀-B,振幅分别为9.92%、9.09%、8.29%。瑞科生物-B公司简介:江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021110551298811ad5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021110551298811ad5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2510472858","title":"瑞科生物-B(02179)股价上升5.085%,现价港币$8.68","url":"https://stock-news.laohu8.com/highlight/detail?id=2510472858","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510472858?lang=zh_cn&edition=full","pubTime":"2025-02-11 10:55","pubTimestamp":1739242500,"startTime":"0","endTime":"0","summary":"[上升股]瑞科生物-B(02179) 股价在上午10:55比前收市价上升5.085%,现股价为港币$8.68。至目前为止,今日最高价为$8.68,而最低价为$8.09。总成交量为3.1万股,总成交金额为港币$26.258万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502111007/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2502060413","title":"瑞科生物-B盘中异动 临近收盘股价大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502060413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502060413?lang=zh_cn&edition=full","pubTime":"2025-01-09 15:47","pubTimestamp":1736408841,"startTime":"0","endTime":"0","summary":"2025年01月09日临近收盘15时47分,瑞科生物-B股票出现异动,股价大幅下跌6.02%。截至发稿,该股报8.270港元/股,成交量1.05万股,换手率0.00%,振幅6.14%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予持有建议,无券商给予买入、卖出建议。瑞科生物-B股票所在的生物技术行业中,整体涨幅为1.31%。瑞科生物-B公司简介:江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109154721aba43aff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109154721aba43aff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2501204397","title":"盘中股价逆市上涨近10%,瑞科生物-B(02179)能否在商业化关键年摆脱流动性陷阱","url":"https://stock-news.laohu8.com/highlight/detail?id=2501204397","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501204397?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:05","pubTimestamp":1736345117,"startTime":"0","endTime":"0","summary":"1月8日,瑞科生物盘中涨幅一度达到9.8%,在普跌的医药板块引起市场关注。2023年,瑞科生物全年成交量为2309.24万股,但到2024年这一数据便锐减至308.20万股。且在11月12日和11月28日,瑞科生物日成交量还分别达到10.80万股和17.30万股。例如,在12月20日,瑞科生物在仅有2500股的日成交量情况下,股价收涨2.88%,足以看出主力资金的高度控盘水平。在女性市场缺乏先发优势下,瑞科生物的九价HPV疫苗商业化预期或不容乐观,但男性市场或成为其一个重要机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1235185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2501761431","title":"瑞科生物-B盘中异动 急速上涨9.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501761431","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501761431?lang=zh_cn&edition=full","pubTime":"2025-01-08 09:51","pubTimestamp":1736301090,"startTime":"0","endTime":"0","summary":"2025年01月08日早盘09时51分,瑞科生物-B股票出现异动,股价急速上涨9.01%。截至发稿,该股报9.680港元/股,成交量1000股,换手率0.00%,振幅0.00%。瑞科生物-B股票所在的生物技术行业中,整体跌幅为0.31%。其相关个股中,瑞科生物-B、腾盛博药-B、药明生物涨幅较大,振幅较大的相关个股有云顶新耀-B、和铂医药-B、腾盛博药-B,振幅分别为8.66%、7.92%、7.00%。瑞科生物-B公司简介:江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010809513095fc25fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010809513095fc25fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2500991631","title":"瑞科生物新疫苗III期临床研究已完成全部受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2500991631","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500991631?lang=zh_cn&edition=full","pubTime":"2025-01-02 13:36","pubTimestamp":1735796166,"startTime":"0","endTime":"0","summary":"财中社1月2日电瑞科生物-B(02179)发布自愿公告,宣布其自主研发的新佐剂重组带状疱疹疫苗REC610的III期临床研究已顺利完成全部受试者的入组。该研究在云南、河南和山西共计18个研究中心招募了24640名40岁及以上的健康受试者,旨在评估疫苗的保护效力、安全性及免疫原性。带状疱疹在中国每年约有600万人罹患,且近年来发病有逐步年轻化的趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202501023285280466.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["III","BK1161","BK4134","02179"],"gpt_icon":0},{"id":"2500499673","title":"瑞科生物:新佐剂重组带状疱疹疫苗REC610完成III期临床研究入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2500499673","media":"金吾资讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500499673?lang=zh_cn&edition=full","pubTime":"2025-01-02 12:34","pubTimestamp":1735792469,"startTime":"0","endTime":"0","summary":"金吾财讯 | 瑞科生物(02179)宣布,公司自主研发的新佐剂重组带状疱疹疫苗REC610 III期临床研究已顺利完成全部受试者的入组。该项临床研究采用随机、双盲、安慰剂对照设计,旨在评估REC610疫苗对40岁及以上健康受试者的保护效力、安全性及免疫原性,已在云南省、河南省和山西省共计18个研究中心招募24,640名受试者。带状疱疹是一种常见的由潜伏感染的病毒引起的疾病,患者可能并发带状疱疹后神经痛,这种剧烈的神经疼痛严重损害患者健康,影响患者生活质量。据统计,中国每年约有600万人罹患带状疱疹,且近年来其发病有逐步年轻化的趋势。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010212343998586487&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010212343998586487&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0},{"id":"2500957819","title":"【瑞科生物-B(02179.HK)新佐剂重组带状疱疹疫苗REC610 完成III期临床研究入组】瑞科生物-B(02179.HK)公布,公司自主研发的新佐剂重组带状疱疹疫苗 REC610 III期临床研究已顺利完成全部受试者的入组。","url":"https://stock-news.laohu8.com/highlight/detail?id=2500957819","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500957819?lang=zh_cn&edition=full","pubTime":"2025-01-02 12:30","pubTimestamp":1735792247,"startTime":"0","endTime":"0","summary":"瑞科生物-B(02179.HK)公布,公司自主研发的新佐剂重组带状疱疹疫苗 REC610 III期临床研究已顺利完成全部受试者的入组。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/02123047027620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159646","02179","BK4134","III","BK1161"],"gpt_icon":0},{"id":"2500995930","title":"瑞科生物-B(02179)新佐剂重组带状疱疹疫苗REC610 完成III期临床研究入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2500995930","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500995930?lang=zh_cn&edition=full","pubTime":"2025-01-02 12:28","pubTimestamp":1735792126,"startTime":"0","endTime":"0","summary":"智通财经APP讯,瑞科生物-B(02179)公布,公司自主研发的新佐剂重组带状疱疹疫苗 REC610 III期临床研究已顺利完成全部受试者的入组。该项临床研究采用随机、双盲、安慰剂对照设计,旨在评估REC610疫苗对40岁及以上健康受试者的保护效力、安全性及免疫原性,已在云南省、河南省和山西省共计18个研究中心招募24,640名受试者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1232308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","02179","BK1161","III","159646"],"gpt_icon":0},{"id":"2500995412","title":"瑞科生物(02179.HK)预防带状疱疹疫苗临床研究完成全部受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2500995412","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500995412?lang=zh_cn&edition=full","pubTime":"2025-01-02 12:27","pubTimestamp":1735792020,"startTime":"0","endTime":"0","summary":"瑞科生物-B(02179.HK) 公布,旗下自主研发的新佐剂重组带状疱疹疫苗REC610,III期临床研究已顺利完成全部受试者的入组。据介绍,相比减毒活疫苗,新佐剂重组带状疱疹疫苗能提供更强的细胞免疫和更高的保护效力,上述REC610拟用于40岁及以上成人中预防带状疱疹。(js/da)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220328112941280_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220328112941280_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1407403/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","159646","02179"],"gpt_icon":0},{"id":"2495159323","title":"瑞科生物-B(02179)股价显著上升11.006%,现价港币$9.38","url":"https://stock-news.laohu8.com/highlight/detail?id=2495159323","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495159323?lang=zh_cn&edition=full","pubTime":"2024-12-30 14:11","pubTimestamp":1735539060,"startTime":"0","endTime":"0","summary":"[上升股]瑞科生物-B(02179) 股价在下午02:11比前收市价显著上升11.006%,现股价为港币$9.38。至目前为止,今日最高价为$9.38,而最低价为$8.61。总成交量为8000股,总成交金额为港币$7.186万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150419953_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR241230914/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02179","BK1161"],"gpt_icon":0},{"id":"2495359869","title":"瑞科生物-B盘中异动 股价大涨6.51%报9.000港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495359869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495359869?lang=zh_cn&edition=full","pubTime":"2024-12-30 13:58","pubTimestamp":1735538290,"startTime":"0","endTime":"0","summary":"2024年12月30日下午盘13时58分,瑞科生物-B股票出现波动,股价快速拉升6.51%。截至发稿,该股报9.000港元/股,成交量3500股,换手率0.00%,振幅4.62%。资金方面,该股资金流入2.208万港元,流出0港元。瑞科生物-B股票所在的生物技术行业中,整体涨幅为0.67%。瑞科生物-B公司简介:江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412301358109854931c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202412301358109854931c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02179"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":0.1051},{"period":"3month","weight":0.0919},{"period":"6month","weight":0.0828},{"period":"1year","weight":0.0765},{"period":"ytd","weight":-0.0368}],"compareEarnings":[{"period":"1week","weight":0.0497},{"period":"1month","weight":0.1515},{"period":"3month","weight":0.1706},{"period":"6month","weight":0.3028},{"period":"1year","weight":0.4122},{"period":"ytd","weight":0.1438}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏瑞科生物技术股份有限公司是一家从事疫苗研发的中国公司。该公司拥有一系列临床和临床前阶段的疫苗,人乳头瘤病毒(HPV)疫苗管线包括重组HPV九价候选疫苗REC603,重组HPV二价候选疫苗REC601及REC602,重组HPV四价疫苗REC604a以及重组HPV九价疫苗REC604b。该公司还参与新冠病毒疫苗的研发。该公司主要在国内市场销售其产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.071825},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.01786},{"month":3,"riseRate":0.5,"avgChangeRate":-0.028356},{"month":4,"riseRate":0,"avgChangeRate":-0.133288},{"month":5,"riseRate":0,"avgChangeRate":-0.068138},{"month":6,"riseRate":0.333333,"avgChangeRate":0.004664},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.028042},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.030435},{"month":9,"riseRate":0.333333,"avgChangeRate":0.008675},{"month":10,"riseRate":0.666667,"avgChangeRate":0.045462},{"month":11,"riseRate":0,"avgChangeRate":-0.122778},{"month":12,"riseRate":1,"avgChangeRate":0.175091}],"exchange":"SEHK","name":"瑞科生物-B","nameEN":"RECBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.1","shortVersion":"4.31.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"瑞科生物-B,02179,瑞科生物-B股票,瑞科生物-B股票老虎,瑞科生物-B股票老虎国际,瑞科生物-B行情,瑞科生物-B股票行情,瑞科生物-B股价,瑞科生物-B股市,瑞科生物-B股票价格,瑞科生物-B股票交易,瑞科生物-B股票购买,瑞科生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"瑞科生物-B(02179)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供瑞科生物-B(02179)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}